CLLS Cellectis

$CLLS The ESGCT 33rd Annual Congress will be held October 27-30, 2026, in Hamburg, Germany. Cellectis will present two posters: P0208: In vivo editing of human apoc3 by tale base editor normalizes triglyceride levels in animal models P0956: TALE: developing a global framework for genome engineering Bio-Europe 2026 will be held November 9-11, 2026 in Cologne, Germany. Arthur Stril, Chief Financial Officer and Chief Business Officer, and Claire Roudot, Associate Director, Business Development and Alliance Management, will attend. The Stifel NYC Healthcare Conference will take place on November 10-12, 2026 in New York. André Choulika, Chief Executive Officer and Arthur Stril, Chief Financial Officer and Chief Business Officer, will give a presentation and host meetings with investors. The Jefferies London Healthcare Conference will take place November 17-19, 2026 in London, UK. André Choulika and Arthur Stril will participate and host meetings with investors.

$CLLS I believe with such good value for money (its target price is 30$+) will be a buying target for astrazeneca (which is already a main shareholder)